File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Neodymium:yttrium-aluminum-garnet laser for the treatment of tracheobronchial recurrences in esophageal carcinomas

TitleNeodymium:yttrium-aluminum-garnet laser for the treatment of tracheobronchial recurrences in esophageal carcinomas
Authors
Issue Date1994
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/athoracsur
Citation
Annals Of Thoracic Surgery, 1994, v. 58 n. 5, p. 1415-1418 How to Cite?
AbstractTracheobronchial recurrence occurred in 55 of 559 patients (9.8%) after resection of their esophageal carcinomas and in 22 of 109 patients (20.2%) after a bypass operation. The risk of airway recurrence increases if residual disease is present in the mediastinum at resection. The median survival of 55 patients diagnosed with tracheobronchial recurrence before July 1988 was 3.7 weeks. After July 1988, there were 22 patients in whom tracheobronchial recurrence developed, 19 of whom were treated by neodymium:yttrium-aluminum-garnet laser under local anesthesia. Additional external radiotherapy was offered to 8 patients who responded to laser treatment and were in satisfactory condition. Four of these patients (21%) had complete tumor regression. Partial regression occurred in 7 patients (37%): 2 were treated by combined therapy and 5 by laser alone. Most tolerated the laser treatment well, but the procedure was abandoned in 6 patients because of smoke inhalation. A tracheoesophageal fistula developed in 2 patients. The median survival for the entire group was 7.4 weeks, with 3 long survivors who lived more than 1 year. The combined application of laser and external radiotherapy is effective for the treatment of tracheobronchial recurrences in patients with esophageal carcinoma.
Persistent Identifierhttp://hdl.handle.net/10722/172705
ISSN
2015 Impact Factor: 2.975
2015 SCImago Journal Rankings: 1.490

 

DC FieldValueLanguage
dc.contributor.authorFok, Men_HK
dc.contributor.authorLaw, SYKen_HK
dc.contributor.authorWong, Jen_HK
dc.date.accessioned2012-10-30T06:24:24Z-
dc.date.available2012-10-30T06:24:24Z-
dc.date.issued1994en_HK
dc.identifier.citationAnnals Of Thoracic Surgery, 1994, v. 58 n. 5, p. 1415-1418en_HK
dc.identifier.issn0003-4975en_HK
dc.identifier.urihttp://hdl.handle.net/10722/172705-
dc.description.abstractTracheobronchial recurrence occurred in 55 of 559 patients (9.8%) after resection of their esophageal carcinomas and in 22 of 109 patients (20.2%) after a bypass operation. The risk of airway recurrence increases if residual disease is present in the mediastinum at resection. The median survival of 55 patients diagnosed with tracheobronchial recurrence before July 1988 was 3.7 weeks. After July 1988, there were 22 patients in whom tracheobronchial recurrence developed, 19 of whom were treated by neodymium:yttrium-aluminum-garnet laser under local anesthesia. Additional external radiotherapy was offered to 8 patients who responded to laser treatment and were in satisfactory condition. Four of these patients (21%) had complete tumor regression. Partial regression occurred in 7 patients (37%): 2 were treated by combined therapy and 5 by laser alone. Most tolerated the laser treatment well, but the procedure was abandoned in 6 patients because of smoke inhalation. A tracheoesophageal fistula developed in 2 patients. The median survival for the entire group was 7.4 weeks, with 3 long survivors who lived more than 1 year. The combined application of laser and external radiotherapy is effective for the treatment of tracheobronchial recurrences in patients with esophageal carcinoma.en_HK
dc.languageengen_US
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/athoracsuren_HK
dc.relation.ispartofAnnals of Thoracic Surgeryen_HK
dc.rightsThe Annals of Thoracic Surgery. Copyright © Elsevier Inc.-
dc.subject.meshBronchial Neoplasms - Mortality - Radiotherapy - Secondaryen_US
dc.subject.meshCombined Modality Therapyen_US
dc.subject.meshEsophageal Neoplasms - Pathology - Surgeryen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLaser Therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshSurvival Rateen_US
dc.subject.meshTracheal Neoplasms - Mortality - Radiotherapy - Secondaryen_US
dc.titleNeodymium:yttrium-aluminum-garnet laser for the treatment of tracheobronchial recurrences in esophageal carcinomasen_HK
dc.typeArticleen_HK
dc.identifier.emailLaw, SYK: slaw@hku.hken_HK
dc.identifier.emailWong, J: jwong@hkucc.hku.hken_HK
dc.identifier.authorityLaw, SYK=rp00437en_HK
dc.identifier.authorityWong, J=rp00322en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/0003-4975(94)91926-7-
dc.identifier.pmid7979668-
dc.identifier.scopuseid_2-s2.0-0027996706en_HK
dc.identifier.hkuros3715-
dc.identifier.volume58en_HK
dc.identifier.issue5en_HK
dc.identifier.spage1415en_HK
dc.identifier.epage1418en_HK
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridFok, M=7005879262en_HK
dc.identifier.scopusauthoridLaw, SYK=7202241293en_HK
dc.identifier.scopusauthoridWong, J=8049324500en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats